{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:16:31Z","timestamp":1762161391053,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":1693,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s13311-018-0661-0","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T13:22:53Z","timestamp":1537190573000},"page":"231-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of 3K3A-Activated Protein C to Treat Neonatal Hypoxic Ischemic Brain Injury in the Spiny Mouse"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3769-1960","authenticated-orcid":false,"given":"Stacey J.","family":"Ellery","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeleine G.","family":"Goss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Brew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayley","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Hale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenic A.","family":"LaRosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flora Y.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1007\/s13311-018-0661-0_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7196\/sajch.574","article-title":"Outcomes of neonates with perinatal asphyxia at a tertiary academic hospital in Johannesburg","volume":"7","author":"Padayachee","year":"2013","journal-title":"S Afri J Child Health"},{"issue":"3","key":"10.1007\/s13311-018-0661-0_bib2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0031-3955(05)70332-1","article-title":"Predicting outcome in hypoxic-ischemic brain injury","volume":"48","author":"Jacinto","year":"2001","journal-title":"Pediatr Clin N Am"},{"issue":"2","key":"10.1007\/s13311-018-0661-0_bib3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ana.23647","article-title":"Neonatal encephalopathy: an inadequate term for hypoxic\u2013ischemic encephalopathy","volume":"72","author":"Volpe","year":"2012","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1007\/s13311-018-0661-0_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.tins.2011.01.005","article-title":"Cytoprotective protein C pathways and implications for stroke and neurological disorders","volume":"34","author":"Zlokovic","year":"2011","journal-title":"Trends Neurosci"},{"issue":"5","key":"10.1007\/s13311-018-0661-0_bib5","first-page":"883","article-title":"Cytoprotective-selective activated protein C therapy for ischaemic stroke","volume":"112","author":"Mosnier","year":"2014","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1007\/s13311-018-0661-0_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/jth.12424","article-title":"Activated protein C accelerates venous thrombus resolution through heme oxygenase-1 induction","volume":"12","author":"Gabre","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1007\/s13311-018-0661-0_bib7","series-title":"Seminars in immunopathology","article-title":"Protein C anticoagulant system\u2014anti-inflammatory effects","author":"Esmon","year":"2012"},{"issue":"8","key":"10.1007\/s13311-018-0661-0_bib8","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.dnarep.2004.03.027","article-title":"The p53 response to DNA damage","volume":"3","author":"Meek","year":"2004","journal-title":"DNA Repair"},{"issue":"5574","key":"10.1007\/s13311-018-0661-0_bib9","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1126\/science.1071699","article-title":"Activation of endothelial cell protease activated receptor 1 by the protein C pathway","volume":"296","author":"Riewald","year":"2002","journal-title":"Science"},{"issue":"3","key":"10.1007\/s13311-018-0661-0_bib10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nm826","article-title":"Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective","volume":"9","author":"Cheng","year":"2003","journal-title":"Nat Med"},{"issue":"14","key":"10.1007\/s13311-018-0661-0_bib11","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1074\/jbc.C100017200","article-title":"Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis","volume":"276","author":"Joyce","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-018-0661-0_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brainres.2008.02.088","article-title":"Effects of activated protein C on neonatal hypoxic ischemic brain injury","volume":"1210","author":"Yesilirmak","year":"2008","journal-title":"Brain Res"},{"issue":"3","key":"10.1007\/s13311-018-0661-0_bib13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/cei.12453","article-title":"Neonatal brain injury and systemic inflammation: modulation by activated protein C ex vivo","volume":"179","author":"Eliwan","year":"2015","journal-title":"Clin Exp Immunol"},{"issue":"9564","key":"10.1007\/s13311-018-0661-0_bib14","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0140-6736(07)60411-5","article-title":"Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial","volume":"369","author":"Nadel","year":"2007","journal-title":"Lancet"},{"issue":"27","key":"10.1007\/s13311-018-0661-0_bib15","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.2174\/138161212802430413","article-title":"Preclinical safety and pharmacokinetic profile of 3K3A-APC, a novel, modified activated protein C for ischemic stroke","volume":"18","author":"Williams","year":"2012","journal-title":"Curr Pharm Des"},{"issue":"5","key":"10.1007\/s13311-018-0661-0_bib16","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1161\/STROKEAHA.108.536680","article-title":"Differential neuroprotection and risk for bleeding from activated protein C with varying degrees of anticoagulant activity","volume":"40","author":"Wang","year":"2009","journal-title":"Stroke"},{"issue":"5","key":"10.1007\/s13311-018-0661-0_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1159\/000232562","article-title":"Neuroprotective Properties of Melatonin in a Model of Birth Asphyxia in the Spiny Mouse (Acomys cahirinus)","volume":"31","author":"Hutton","year":"2009","journal-title":"Dev Neurosci"},{"key":"10.1007\/s13311-018-0661-0_bib18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.neuroscience.2011.05.012","article-title":"A maternal diet supplemented with creatine from mid-pregnancy protects the newborn spiny mouse brain from birth hypoxia","volume":"194","author":"Ireland","year":"2011","journal-title":"Neuroscience"},{"issue":"2","key":"10.1007\/s13311-018-0661-0_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/pr.2012.174","article-title":"Creatine pretreatment prevents birth asphyxia-induced injury of the newborn spiny mouse kidney","volume":"73","author":"Ellery","year":"2012","journal-title":"Pediatr Res"},{"issue":"4","key":"10.1007\/s13311-018-0661-0_bib20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/pr.2016.268","article-title":"Renal dysfunction in early adulthood following birth asphyxia in male spiny mice, and its amelioration by maternal creatine supplementation during pregnancy","volume":"81","author":"Ellery","year":"2016","journal-title":"Pediatr Res"},{"issue":"3","key":"10.1007\/s13311-018-0661-0_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149840","article-title":"Maternal creatine supplementation during pregnancy prevents long-term changes in diaphragm muscle structure and function after birth asphyxia","volume":"11","author":"LaRosa","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1007\/s13311-018-0661-0_bib22","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/pr.2016.153","article-title":"Maternal creatine supplementation during pregnancy prevents acute and long-term deficits in skeletal muscle after birth asphyxia: a study of structure and function of hind limb muscle in the spiny mouse","volume":"80","author":"LaRosa","year":"2016","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1007\/s13311-018-0661-0_bib23","first-page":"4","article-title":"Managing a colony of spiny mice (Acomys cahirinus) for perinatal research","volume":"20","author":"Dickinson","year":"2007","journal-title":"In: Australian and New Zealand Council for the Care of Animals in Research and Training (ANZCCART) News"},{"issue":"42","key":"10.1007\/s13311-018-0661-0_bib24","doi-asserted-by":"crossref","first-page":"7479","DOI":"10.2174\/1381612819666131230131454","article-title":"Phase 1 safety, tolerability and pharmacokinetics of 3K3A-APC in healthy adult volunteers","volume":"19","author":"Lyden","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1007\/s13311-018-0661-0_bib25","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J"},{"issue":"7","key":"10.1007\/s13311-018-0661-0_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol"},{"year":"2007","series-title":"Atlas of the developing mouse brain: At E17.5, PO, and P6","author":"Paxinos","key":"10.1007\/s13311-018-0661-0_bib27"},{"issue":"4\u20135","key":"10.1007\/s13311-018-0661-0_bib28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000105475","article-title":"Uteroplacental inflammation results in blood brain barrier breakdown, increased activated caspase 3 and lipid peroxidation in the late gestation ovine fetal cerebellum","volume":"29","author":"Hutton","year":"2007","journal-title":"Dev Neurosci"},{"key":"10.1007\/s13311-018-0661-0_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fncel.2013.00003","article-title":"Quantitating the subtleties of microglial morphology with fractal analysis","volume":"7","author":"Karperien","year":"2013","journal-title":"Front Cell Neurosci"},{"year":"2015","series-title":"Applied regression analysis and generalized linear models","author":"Fox","key":"10.1007\/s13311-018-0661-0_bib30"},{"issue":"9","key":"10.1007\/s13311-018-0661-0_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/aps.2013.89","article-title":"Inflammatory responses in hypoxic ischemic encephalopathy","volume":"34","author":"Liu","year":"2013","journal-title":"Acta Pharmacol Sin"},{"key":"10.1007\/s13311-018-0661-0_bib32","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-02-769026","article-title":"Activated protein C, protease activated receptor 1 and neuroprotection","author":"Griffin","year":"2018","journal-title":"Blood"},{"issue":"4","key":"10.1007\/s13311-018-0661-0_bib33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrneurol.2015.13","article-title":"The role of inflammation in perinatal brain injury","volume":"11","author":"Hagberg","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1007\/s13311-018-0661-0_bib34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0165-3806(94)00177-2","article-title":"Microglia activation after neonatal hypoxic-ischemia","volume":"84","author":"McRae","year":"1995","journal-title":"Dev Brain Res"},{"issue":"12","key":"10.1007\/s13311-018-0661-0_bib35","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.tins.2009.08.002","article-title":"Molecular dissection of reactive astrogliosis and glial scar formation","volume":"32","author":"Sofroniew","year":"2009","journal-title":"Trends Neurosci"},{"issue":"5","key":"10.1007\/s13311-018-0661-0_bib36","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/ana.23670","article-title":"STAT3-Mediated astrogliosis protects myelin development in neonatal brain injury","volume":"72","author":"Nobuta","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-018-0661-0_bib37","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1074\/jbc.C100017200","article-title":"Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis","volume":"276","author":"Joyce","year":"2001","journal-title":"J Biol Chem"},{"issue":"20","key":"10.1007\/s13311-018-0661-0_bib38","doi-asserted-by":"crossref","first-page":"19808","DOI":"10.1074\/jbc.M500747200","article-title":"Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling","volume":"280","author":"Riewald","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-018-0661-0_bib39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neulet.2013.11.019","article-title":"Apoptosis-related proteins are potential markers of neonatal hypoxic\u2013ischemic encephalopathy (HIE) injury","volume":"558","author":"Hern\u00e1ndez-Jim\u00e9nez","year":"2014","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1007\/s13311-018-0661-0_bib40","first-page":"103","article-title":"Effect of recombinant human activated protein C on apoptosis-related proteins","volume":"51","author":"Sakar","year":"2007","journal-title":"Eur J Histochem"},{"issue":"1","key":"10.1007\/s13311-018-0661-0_bib41","first-page":"123","article-title":"Increased Bax\/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis","volume":"21","author":"Salakou","year":"2007","journal-title":"In Vivo"},{"key":"10.1007\/s13311-018-0661-0_bib42","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/S0049-3848(16)30368-1","article-title":"Activated protein C promotes neuroprotection: mechanisms and translation to the clinic","volume":"141","author":"Griffin","year":"2016","journal-title":"Thromb Res"},{"issue":"10","key":"10.1007\/s13311-018-0661-0_bib43","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/hc3501.093799","article-title":"Activated protein C prevents endotoxin-induced hypotension in rats by inhibiting excessive production of nitric oxide","volume":"104","author":"Isobe","year":"2001","journal-title":"Circulation"},{"issue":"2","key":"10.1007\/s13311-018-0661-0_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031017","article-title":"Developmental programming of cardiovascular dysfunction by prenatal hypoxia and oxidative stress","volume":"7","author":"Giussani","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1007\/s13311-018-0661-0_bib45","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1253\/circj.CJ-13-0311","article-title":"Vitamin C prevents intrauterine programming of in vivo cardiovascular dysfunction in the rat","volume":"77","author":"Kane","year":"2013","journal-title":"Circ J"},{"issue":"2","key":"10.1007\/s13311-018-0661-0_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009250","article-title":"Antioxidant treatment alters peripheral vascular dysfunction induced by postnatal glucocorticoid therapy in rats","volume":"5","author":"Herrera","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1007\/s13311-018-0661-0_bib47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0165-3806(89)90055-2","article-title":"A comparative study of prenatal development in the olfactory bulb, neocortex and hippocampal region of the precocial mouse (Acomys cahirinus) and rat","volume":"49","author":"Brunjes","year":"1989","journal-title":"Dev Brain Res"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-018-0661-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-018-0661-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923010127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923010127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-018-0661-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:47:09Z","timestamp":1761806829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923010127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1878747923010127"],"URL":"https:\/\/doi.org\/10.1007\/s13311-018-0661-0","relation":{},"ISSN":["1878-7479"],"issn-type":[{"type":"print","value":"1878-7479"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of 3K3A-Activated Protein C to Treat Neonatal Hypoxic Ischemic Brain Injury in the Spiny Mouse","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-018-0661-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}